Evaluation of a Diabetes Data Management System

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Bayer HealthCare, Diabetes Care
ClinicalTrials.gov Identifier:
NCT00694070
First received: June 6, 2008
Last updated: January 26, 2012
Last verified: January 2012
Results First Received: July 1, 2009  
Study Type: Observational
Study Design: Observational Model: Case-Only;   Time Perspective: Cross-Sectional
Condition: Diabetes

  Participant Flow
  Hide Participant Flow

Recruitment Details
Key information relevant to the recruitment process for the overall study, such as dates of the recruitment period and locations
No text entered.

Pre-Assignment Details
Significant events and approaches for the overall study following participant enrollment, but prior to group assignment
No text entered.

Reporting Groups
  Description
Health Care Professionals and Lay Users h= 8 health care professionals p= 43 lay users

Participant Flow:   Overall Study
    Health Care Professionals and Lay Users  
STARTED     51  
COMPLETED     51  
NOT COMPLETED     0  



  Baseline Characteristics
  Hide Baseline Characteristics

Reporting Groups
  Description
Health Care Professionals and Lay Users h= 8 health care professionals p= 43 lay users

Baseline Measures
    Health Care Professionals and Lay Users  
Number of Participants  
[units: participants]
  51  
Age  
[units: years]
Median ( Full Range )
  53  
  ( 18 to 82 )  
Gender  
[units: participants]
 
Female     29  
Male     22  



  Outcome Measures
  Show All Outcome Measures

1.  Primary:   Number of Participants That Rated 80% of Tasks as Very Simple, Simple, or Neither Simple Nor Difficult (Ease of Use of the Software Program)   [ Time Frame: 1-2 hours ]

2.  Primary:   Number of Participants Rated as <= 3 (Success in Using the Program)   [ Time Frame: 1-2 hours ]

3.  Primary:   Number of Participants That Could Answer at Least 85% of the Comprehension Questions Correctly (Comprehension of the Program Reports)   [ Time Frame: 1-2 hours ]


  Serious Adverse Events


  Other Adverse Events


  More Information